Literature DB >> 20981460

Theoretical study of hydrogen bond interactions of fluvastatin with ι-carrageenan and λ-carrageenan.

Anastasios G Papadopoulos1, Michael P Sigalas.   

Abstract

The binding of the reductase inhibitor drug fluvastatin, hydroxy-3-methylglutaryl coenzyme A, with the hydrophilic ι- or λ-carrageenan polymers, serving as potential controllers of the drug's release rate, have been studied at the density functional level of theory with the B3LYP exchange correlation functional. Three low energy conformers of fluvastatin have been calculated. The vibrational spectroscopic properties calculated for the most stable conformer were in satisfactory agreement with the experimental data. A series of hydrogen bonded complexes of the most stable conformer of fluvastatin anion with low molecular weight models of the polymers have been fully optimized. In almost all, intermolecular H-bonds are formed between the sulfate groups of ι- or λ-carrageenan and fluvastatin's hydroxyls, resulting in a red shift of the fluvastatin's O - H stretching vibrations. Cooperative intramolecular H-bonds within fluvastatin or ι-, λ-carrageenan are also present. The BSSE and ZPE corrected interaction energies were estimated in the range 281-318 kJ mol⁻¹ for ι-carrageenan - fluvastatin and 145-200 kJ mol⁻¹ for λ-carrageenan - fluvastatin complexes. The electron density (ρ (bcp)) and Laplacian (∇²ρ (bcp)) properties at critical points of the intermolecular hydrogen bonds, estimated by AIM (atoms in molecules) calculations, have a low and positive character (∇²ρ(bcp) > 0), consistent with the electrostatic character of the hydrogen bonds. The structural and energetic data observed, as well as the extent of the red shift of the fluvastatin's O - H stretching vibrations upon complex formation and the properties of electron density show a stronger binding of fluvastatin to ι- than to λ-carrageenan.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20981460     DOI: 10.1007/s00894-010-0878-2

Source DB:  PubMed          Journal:  J Mol Model        ISSN: 0948-5023            Impact factor:   1.810


  19 in total

Review 1.  Solid dispersion of poorly water-soluble drugs: early promises, subsequent problems, and recent breakthroughs.

Authors:  A T Serajuddin
Journal:  J Pharm Sci       Date:  1999-10       Impact factor: 3.534

2.  Direct-injection LC-MS-MS method for high-throughput simultaneous quantitation of simvastatin and simvastatin acid in human plasma.

Authors:  M Jemal; Z Ouyang; M L Powell
Journal:  J Pharm Biomed Anal       Date:  2000-08-15       Impact factor: 3.935

Review 3.  Potential role of statins in inflammation and atherosclerosis.

Authors:  Masayuki Yoshida
Journal:  J Atheroscler Thromb       Date:  2003       Impact factor: 4.928

4.  Development of the Colle-Salvetti correlation-energy formula into a functional of the electron density.

Authors: 
Journal:  Phys Rev B Condens Matter       Date:  1988-01-15

5.  Effect of statins on risk of coronary disease: a meta-analysis of randomized controlled trials.

Authors:  J C LaRosa; J He; S Vupputuri
Journal:  JAMA       Date:  1999 Dec 22-29       Impact factor: 56.272

6.  The interconversion kinetics, equilibrium, and solubilities of the lactone and hydroxyacid forms of the HMG-CoA reductase inhibitor, CI-981.

Authors:  A S Kearney; L F Crawford; S C Mehta; G W Radebaugh
Journal:  Pharm Res       Date:  1993-10       Impact factor: 4.200

7.  Interactions of poly(vinylpyrrolidone) with ibuprofen and naproxen: experimental and modeling studies.

Authors:  Svetla Bogdanova; Ilza Pajeva; Petya Nikolova; Ivanka Tsakovska; Bernd Müller
Journal:  Pharm Res       Date:  2005-05-17       Impact factor: 4.200

Review 8.  Effects of statins beyond lipid lowering: potential for clinical benefits.

Authors:  Khalid Almuti; Rola Rimawi; Daniel Spevack; Robert J Ostfeld
Journal:  Int J Cardiol       Date:  2005-07-28       Impact factor: 4.164

9.  DFT study on hydroxy acid-lactone interconversion of statins: The case of fluvastatin.

Authors:  Tomasz Grabarkiewicz; Pawel Grobelny; Marcin Hoffmann; Jadwiga Mielcarek
Journal:  Org Biomol Chem       Date:  2006-10-25       Impact factor: 3.876

10.  Controlled-release tablets from carrageenans: effect of formulation, storage and dissolution factors.

Authors:  V K Gupta; M Hariharan; T A Wheatley; J C Price
Journal:  Eur J Pharm Biopharm       Date:  2001-05       Impact factor: 5.571

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.